Discovery

University of Washington receives USD 2.1m NIH award for spatial transcriptomics technology development

A USD 2.1 million NIH R01 award positions the University of Washington at the center of an emerging effort to overcome a fundamental throughput bottleneck in spatial transcriptomics, reflecting sustained NIH investment in enabling technologies that could reshape how tissue biology is studied at scale.

Spectral barcoding as a route beyond current multiplexing limits

The grant, administered by the National Institute of General Medical Sciences (NIGMS) and running from May 2026 through April 2030, funds the development of a library of more than 1,000 spectrally barcoded fluorescent probes designed for single-round, high-resolution spatial transcriptomics in both thin and thick tissue samples. The work is led by Daniel T. Chiu and Joshua Vaughan in the university's Department of Chemistry.

The core technical challenge the award addresses is well established in the field. Existing imaging-based spatial transcriptomics platforms — including commercial systems built on cyclic smFISH approaches — require multiple sequential rounds of staining, imaging, and probe removal to achieve high gene counts. Sequencing-based alternatives offer broader coverage but sacrifice spatial resolution and add cost and complexity. Neither approach is currently compatible with thick tissue sections, which preserve three-dimensional architecture and are increasingly used in research settings.

The UW research funding targets this gap directly. By encoding spectral identity into fluorescent probes and pairing them with DNA oligonucleotide adapters, the team aims to create a modular 1,024-probe library in which any mRNA target can be labeled by swapping the adapter sequence rather than redesigning the barcode probe itself. The architecture is intended to decouple probe synthesis from target selection, which could lower the barrier to adoption across diverse research applications.

From probe library to tissue atlas

University of Washington research grants in the spatial biology space have increasingly emphasized translational utility alongside technology development, and this award follows that pattern. Aims 2 and 3 of the project apply the new probe set to constructing a spatial cell atlas of the kidney glomerulus in adult and aged mouse tissue, complementing existing work at the institution on protein and carbohydrate imaging of the same structure.

The AllSci BriefSystematic R&D and deal news. Daily.

The glomerulus use case is not incidental. Glomerular disease underlies a range of chronic kidney conditions, and spatially resolved gene expression data from this structure — particularly across age groups — could inform both basic mechanistic research and translational studies in nephrology. The choice of a well-defined anatomical target with clinical relevance reflects a broader NIH expectation that technology development grants demonstrate impact through concrete biological applications.

The project's intermediate milestone — 128-plex single-round mRNA imaging in both thin and thick tissues — is itself a substantial step beyond current single-round capabilities, which typically support one to two orders of magnitude fewer simultaneous targets. The stated longer-term goal of scaling toward the full 1,024-plex capacity frames the four-year award as an early phase of what the investigators describe as an expandable platform.

The total award of USD 2.1 million, comprising USD 1.35 million in direct costs and USD 750,000 in indirect costs, places this among the larger single-R01 investments in spatial biology instrumentation currently active at the institution.


This article was generated with AI assistance and reviewed and edited by the AllSci editorial team Explore more at AllSci News: https://allsci.com/news/


Spot something wrong? Report an issue with this article